Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
kr136.49 Mil
% of Total Estimate Gain
21.42%

Variable Portfolio - Partners International Core Equity Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, Variable Portfolio - Partners International Core Equity Fund held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and Variable Portfolio - Partners International Core Equity Fund now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q3. And since then Variable Portfolio - Partners International Core Equity Fund has made 3 purchases of OCSE:NOVO B, at an average price of kr274.61, for a total of 2.32 Mil shares. In addition, there have been 11 sales at an average price of kr333.45 for 2.32 Mil shares. Based on historical transaction data and OCSE:NOVO B's current price of kr451.30, Variable Portfolio - Partners International Core Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr136.49 Mil, reflecting a 21.42% gain to date.

Variable Portfolio - Partners International Core Equity Fund OCSE:NOVO B (kr451.30) Holding Chart

Variable Portfolio - Partners International Core Equity Fund OCSE:NOVO B (kr451.30) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1